Loading…

Medical Research Finder

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Immune Checkpoint Inhibitors (ICIs) & Non-Small-Cell Lung Carcinoma (NSCLC) (adenocarcinoma)

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

PD-L1 expression is significantly associated with clinical response to anti-PD-1/PD-L1 antibodies in non-squamous NSCLC pts
Gandini et al., 2016

Immunotherapy combinations in advanced nonsmall cell lung cancer
Pirker 2020b Current Opinion in Oncology 33(1): 73-79
Review
Immunotherapy Utilization Among Patients With Metastatic NSCLC: Impact of Comorbidities
Zhang et al. 2021i J. of Immunotherapy 44: 198-203
PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis
Gandini et al., 2016
Review

5/29/2026